INFU icon

InfuSystem Holdings

8.31 USD
+0.35
4.40%
At close Dec 20, 4:00 PM EST
After hours
8.31
+0.00
0.00%
1 day
4.40%
5 days
-7.56%
1 month
-7.87%
3 months
28.64%
6 months
29.44%
Year to date
-18.45%
1 year
-21.38%
5 years
-3.82%
10 years
187.54%
 

About: InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.

Employees: 516

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

225% more call options, than puts

Call options by funds: $13K | Put options by funds: $4K

150% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 14

0% more funds holding

Funds holding: 78 [Q2] → 78 (+0) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q2] → 2 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

0.67% less ownership

Funds ownership: 65.55% [Q2] → 64.88% (-0.67%) [Q3]

3% less capital invested

Capital invested by funds: $95.3M [Q2] → $92.7M (-$2.68M) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$13
56%
upside
Avg. target
$13
56%
upside
High target
$13
56%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
B. Riley Securities
56%upside
$13
Buy
Initiated
26 Sept 2024

Financial journalist opinion

Neutral
Business Wire
4 weeks ago
InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024.
InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024
Neutral
Business Wire
1 month ago
InfuSystem Appoints Ronald Hundzinski to the Board of Directors
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Appoints Ronald Hundzinski to the Board of Directors.
InfuSystem Appoints Ronald Hundzinski to the Board of Directors
Neutral
Seeking Alpha
1 month ago
InfuSystem Holdings, Inc. (INFU) Q3 2024 Earnings Call Transcript
InfuSystem Holdings, Inc. (NYSE:INFU ) Q3 2024 Results Conference Call November 7, 2024 9:00 AM ET Company Participants Joe Dorame - Managing Partner Rich Dilorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Jim Sidoti - Sidoti & Company Brooks O'Neil - Lake Street Capital Markets Kyle Bauser - B. Riley Securities Matt Hewitt - Craig-Hallum Capital Group Aaron Warwick - Breakout Investors Operator Good day, and welcome to the InfuSystem Third Quarter of 2024 Financial Results Conference Call.
InfuSystem Holdings, Inc. (INFU) Q3 2024 Earnings Call Transcript
Neutral
Business Wire
1 month ago
InfuSystem Reports Third Quarter 2024 Financial Results
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Reports Third Quarter 2024 Financial Results.
InfuSystem Reports Third Quarter 2024 Financial Results
Neutral
Business Wire
1 month ago
InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024.
InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024
Positive
MarketBeat
2 months ago
The Future of Medical Devices: Two Strong Buys You Can't Miss
The medical device market, a powerhouse sector, is projected to exceed $600 billion by 2025. This growth is fueled by a combination of factors, including an aging population, rising healthcare costs, and rapid technological advancements powered by advanced artificial intelligence (AI) and biotechnology.
The Future of Medical Devices: Two Strong Buys You Can't Miss
Neutral
Business Wire
2 months ago
InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024.
InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024
Neutral
Business Wire
3 months ago
InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, and its joint venture partner Sanara MedTech Inc. (“Sanara”), announced today the execution of an exclusive United States distribution agreement with ChemoMouthpiece, LLC (“ChemoMouthpiece”).
InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC
Neutral
Business Wire
3 months ago
InfuSystem to Participate in Lake Street's 8th Annual Best Ideas Growth (BIG8) Conference September 12, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate in Lake Street's 8th Annual Best Ideas Growth (BIG8) Conference September 12, 2024.
InfuSystem to Participate in Lake Street's 8th Annual Best Ideas Growth (BIG8) Conference September 12, 2024
Positive
Seeking Alpha
3 months ago
InfuSystem Set For Strong Second Half
InfuSystem's stock could soar in late 2024 and throughout 2025 after consolidating in the sub-$7.00/share range. INFU's underlying business is stronger than ever, with new partnerships and revenue streams set to surprise the market. The company's pivot toward partnering with established players is expected to drive revenue growth and expanding margins.
InfuSystem Set For Strong Second Half
Charts implemented using Lightweight Charts™